Código QR

Efficacy of an Indian Bevacizumab BIOSimilar (BEVATAS) for Type 1 and Aggressive Posterior Retinopathy of Prematurity (BIOS-ROP Study)

Somnath Chakraborty,1 Jay Umed Sheth2 1Department of Vitreoretinal Services, Retina Institute of Bengal, Siliguri, India; 2Department of Vitreoretinal Services, Shantilal Shanghvi Eye Institute, Mumbai, MH, IndiaCorrespondence: Somnath Chakraborty, Department of Vitreoretinal Services, Retina Instit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Chakraborty S, Sheth JU
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2024-01-01
Series:Clinical Ophthalmology
Assuntos:
Acceso en liña:https://www.dovepress.com/efficacy-of-an-indian-bevacizumab-biosimilar-bevatas-for-type-1-and-ag-peer-reviewed-fulltext-article-OPTH
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!